What is the current Price Target for the Altamira Therapeutics Ltd stock?

The average Altamira Therapeutics Ltd target price is $5.41. This is 10,479.30% higher than the current stock price. The highest price target is 10,790.41%, the lowest is 10,375.54%. 3 Analysts have issued a price target Altamira Therapeutics Ltd 2026 .

How high will the Altamira Therapeutics Ltd stock rise?

No reliable answer can be given as to how high the Altamira Therapeutics Ltd stock will rise. The performance of stocks, including the Altamira Therapeutics Ltd stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Altamira Therapeutics Ltd stock today?

The performance of Altamira Therapeutics Ltd stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Altamira Therapeutics Ltd stock fall?

The decline in Altamira Therapeutics Ltd stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Altamira Therapeutics Ltd Forecast, price target & analysts

$0.05

43.22%

Nasdaq, Thu, Sep 11 2025

ISIN

BMG0360L1000

Symbol

CYTO

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Overview Dividends Analysts Charts Strategies

Altamira Therapeutics Ltd Target price 2025 - Analyst rating & recommendation

Altamira Therapeutics Ltd Classifications & Recommendation:

Buy

89%

Hold

11%

Altamira Therapeutics Ltd Price Target

Target Price	$5.41
Price	$0.05
Potential	10,479.30% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Altamira Therapeutics Ltd 2026 . The average Altamira Therapeutics Ltd target price is $5.41. This is 10,479.30% register free of charge higher than the current stock price. The highest price target is $5.57 10,790.41% register free of charge , the lowest is $5.35 10,375.54% register free of charge .
	A rating was issued by 9 analysts: 8 Analysts recommend Altamira Therapeutics Ltd to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Altamira Therapeutics Ltd stock has an average upside potential 2026 of 10,479.30% register free of charge . Most analysts recommend the Altamira Therapeutics Ltd stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-2.99	-1.21
	65.87%	59.53%
P/E		negative

4 Analysts have issued a Altamira Therapeutics Ltd forecast for earnings per share. The average Altamira Therapeutics Ltd EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-2.99	65.87%
2025	$-1.21 59.53% Unlock
2026	$-1.66 37.19% Unlock

Current	-0.02	99.69%
2025	-0.04 83.49% Unlock
2026	-0.03 25.00% Unlock

Altamira Therapeutics Ltd...

Discover more stocks with a high price target

BioNTech SE - ADR 33.48%

TUI 32.71%

Deutsche Telekom 29.16%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now